Quick Answer
Editas Medicine, Inc. reported Stockholders Equity of $27.29 million for fiscal year 2025.
Editas Medicine, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $27.29M | -79.7% |
| 2024 | $134.27M | -61.5% |
| 2023 | $349.10M | -3.2% |
| 2022 | $360.68M | -34.9% |
| 2021 | $553.64M | +40.7% |
| 2020 | $393.59M | +50.0% |
| 2019 | $262.44M | +11.1% |
| 2018 | $236.16M | +13.5% |
| 2017 | $208.08M | +54.6% |
| 2016 | $134.61M | +262.0% |
| 2015 | -$83.11M | -443.5% |
| 2014 | -$15.29M | -767.4% |
| 2013 | -$1.76M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $13.45M | -92.3% | -29.9% |
| June 30, 2025 | $19.19M | -91.7% | -69.3% |
| March 31, 2025 | $62.42M | -78.8% | -53.5% |
| December 31, 2024 | $134.27M | -61.5% | -23.5% |
| September 30, 2024 | $175.63M | -51.3% | -24.3% |
| June 30, 2024 | $232.01M | -42.0% | -21.2% |
| March 31, 2024 | $294.40M | -7.3% | -15.7% |
| December 31, 2023 | $349.10M | -3.2% | -3.2% |
- Editas Medicine, Inc. showed a decrease of -79.7% in Stockholders Equity compared to the prior fiscal year.
- Over the 2013–2025 period, Editas Medicine, Inc.’s stockholders equity has grown by 1647.8% (from -$1.76 million to $27.29 million).
- The most recent figure is from Editas Medicine, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: